Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Int J Cancer. 2014 Dec 10;137(1):204–211. doi: 10.1002/ijc.29351

Table 2.

Patient demographics for study cohort comparing the total cohort to those that achieved optimal DPE (NED) and those that achieved optimal RT (Appropriate). p-values refer to the comparison of the distribution of patient characteristic between those that achieved NED or appropriate RT and those that did not. N-0, no nodal disease; N-1 nodal disease; T-1 not tumor invasion of adjacent structures; T-2 tumor invasion of adjacent structures.

Baseline Characteristic Total (n=161) NED (n=43) Appropriate RT (n=38) p-value comparing NED (n=43) to other patients (n=118) p-value comparing appropriate RT (n=38) to other patients (n=123)
Count (%) Count (%) Count (%)
Age (years)
<1 5 (3%) 2 (5%) 1 (3%)
1 to 9 118 (73%) 29 (67%) 29 (76%)
10+ 38 (24%) 12 (28%) 8 (21%) 0.49 0.93
Histology
Embryonal 84 (52%) 20 (49%) 22 (61%)
Alveolar 65 (40%) 21 (51%) 14 (39%) 0.27 0.57
Tumor Size
≤ 5 cm 39 (24%) 12 (28%) 10 (26%)
>5 cm 121 (76%) 31 (72%) 28 (74%) 0.54 0.83
Tumor Stage
2 33 (20%) 8 (19%) 9 (24%)
3 128 (80%) 35 (81%) 29 (76%) 0.83 0.65
Tumor Invasion
T-1 88 (55%) 25 (58%) 26 (68%)
T-2 72 (45%) 18 (42%) 12 (32%) 0.72 0.06
Anatomic Sites
Extremity 63(39%) 23 (53%) 17 (45%)
Bladder Dome 24 (15%) 6 (14%) 6 (13%)
Trunk/Retroperitoneum/Perineal/Perianal/Intra-thoracic/GI/Biliary 74 (46%) 14 (33%) 16 (42%) 0.07 0.75
Response at week 12
NR 30/149 (20%) 6 (14%) 5 (16%)
PR 101/149 (68%) 23 (53%) 17 (45%)
CR 18/149 (12%) 14 (33%) 16 (42%) <0.001 <0.001